×
Quality of and Patient Satisfaction With Primary Health Care for Anxiety Disorders PDF
$ 40.00
Quality of and Patient Satisfaction With Primary Health Care for Anxiety Disorders PDF quantity
$ 40.00
×
Desvenlafaxine 50 and 100 mg/d Versus Placebo for the Treatment of Major Depressive Disorder: A Phase 4, Randomized Controlled Trial PDF
$ 40.00
Desvenlafaxine 50 and 100 mg/d Versus Placebo for the Treatment of Major Depressive Disorder: A Phase 4, Randomized Controlled Trial PDF quantity
$ 40.00
×
Antidepressant Use in Elderly Suicide Victims in New York City: An Analysis of 255 Cases PDF
$ 40.00
Antidepressant Use in Elderly Suicide Victims in New York City: An Analysis of 255 Cases PDF quantity
$ 40.00
×
Rapid Development of Lorazepam Tolerance Within 48 Hours in an Adult With Intellectual Disability Who Presented With Stuporous Catatonia and Refused Electroconvulsive Therapy PDF
$ 40.00
Rapid Development of Lorazepam Tolerance Within 48 Hours in an Adult With Intellectual Disability Who Presented With Stuporous Catatonia and Refused Electroconvulsive Therapy PDF quantity
$ 40.00
×
Efficacy of Dose Increase Among Nonresponders to Low-Dose Aripiprazole Augmentation in Patients With Inadequate Response to Antidepressant Treatment: A Randomized, Double-Blind, Placebo-Controlled, Efficacy Trial PDF
$ 40.00
Efficacy of Dose Increase Among Nonresponders to Low-Dose Aripiprazole Augmentation in Patients With Inadequate Response to Antidepressant Treatment: A Randomized, Double-Blind, Placebo-Controlled, Efficacy Trial PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart
